Dental
pain, also known
as odontogenic pain or tooth pain, arises from the teeth or their supporting
structures which includes mucosa, gingivae, maxilla, mandible, or periodontal
membrane.
Request
to Get the Sample Pages at: https://www.pharmaproff.com/request-sample/1129
The primary
location of the reflected pain (orofacial pain) is the spinal core of
trigeminal system. The trigeminal nerve provides sensory and motor innervation
to the scalp, face, and mouth. Pulpal pain, periodontal pain, gingival pain,
and bone pain are different types of pain originates from the dental area.
Moreover, post-endodontic surgery pain, one of the severe types of pain, occurs
due to apicectomy or root canal therapy.
Access
Detailed Report Summary: https://www.pharmaproff.com/report/dental-pain-therapeutics-pipeline-analysis
Pericoronitis
is an inflammation of soft tissues and is the common cause for removal of
wisdom teeth. Percussion test, probing, pulp sensitivity test, palpation,
mobility test, sinus formation, and radiographic examination are some of the
most common test used to diagnose dental problems.
Stony Brook
University, and Antibe Therapeutics Inc. are some of the key companies and
universities involved in development of dental pain therapeutics. Antibe
Therapeutics Inc. is developing ATB-352 for the treatment of dental pain.
The report
provides a comprehensive understanding of the pipeline activities covering all
drug candidates under various stages of development, with the detailed analysis
of pipeline and clinical trials.
Pipeline
analysis of drugs by phases includes product description and development
activities including information about clinical results, designations,
collaborations, licensing, grants, technology, and others.